Delivery Order SPE2DE24D0013-SPE2D625F4GHH

The Defense Logistics Agency's Medical Supply Chain division awarded a $13.8K firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, with an ultimate completion date of October 3, 2025. This delivery order, which carries no set-aside designation, represents a continuation of the federal government's procurement of Cepheid's diagnostic testing capabilities and equipment. Cepheid specializes in advanced molecular diagnostic systems, including its GeneXpert platform and associated reagents and test kits, designed to detect infectious diseases and clinical conditions ranging from COVID-19 and influenza to MRSA and sexually transmitted infections.

This award builds upon Cepheid's established relationship with the Department of Defense and Veterans Affairs, where the company holds two significant Indefinite Delivery Vehicles valued at $32.8M (VA Veterans Integrated Service Network 6) and $2.5M (VA Veterans Integrated Service Network 21), both extending through 2030. These framework contracts provide ongoing access to molecular diagnostic testing systems and PCR reagents for laboratory microbiology across the federal healthcare enterprise, supporting critical diagnostic needs for infectious disease detection and treatment decision-making across Veterans Integrated Service Networks and other federal health agencies.